SigmaMAb Bevacizumab (MSQC20) was designed to be a standard for the analysis of Bevacizumab monoclonal antibodies using mass spectrometry. An isotopically labeled version is available as SILu(TM)Mab Bevacizumab (MSQC21). SigmaMAb Bevacizumab is for R&D use only. Not for drug, household, or other uses.
Purity: >=90% (SDS-PAGE)
Storage: -20C
Legal Information: SILu is a trademark of Sigma-Aldrich Co. LLC